Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.24 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 41.08.
Market Cap
8.24T
Revenue
4.59T
Profits
200.64B
PE Ratio
41.08
Profit Margin
4.38%
Dividend Yield
0.43%
1064 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 882.71B | 2.37% | 3,036,748 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 539.84B | 1.28% | 8,626,506 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 367.25B | 2.51% | 7,043,916 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 359.98B | 3.11% | 9,258,333 | 449.71B |
| 5 | AZN | AstraZeneca PLC | 287.98B | 1.47% | 1,596,069 | 60.44B |
| 6 | NVS | Novartis AG | 282.72B | 2.02% | 921,769 | 56.58B |
| 7 | MRK | Merck & Co., Inc. | 277.53B | 0.98% | 9,117,341 | 65.77B |
| 8 | NVO | Novo Nordisk A/S | 206.25B | 1.29% | 14,248,177 | 50.57B |
| 9 | AMGN | Amgen Inc. | 181.50B | 2.03% | 3,218,929 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 170.69B | 1.48% | 3,055,733 | 45.20B |
| 11 | GILD | Gilead Sciences, Inc. | 167.54B | 1.06% | 6,034,713 | 29.74B |
| 12 | ISRG | Intuitive Surgical, Inc. | 152.95B | 2.81% | 2,351,316 | 10.58B |
| 13 | PFE | Pfizer Inc. | 147.44B | 0.23% | 26,819,826 | 63.32B |
| 14 | ABT | Abbott Laboratories | 146.92B | 2.17% | 16,392,507 | 45.13B |
| 15 | CVS | CVS Health Corporation | 121.40B | 3.18% | 12,802,554 | 405.62B |
| 16 | DHR | Danaher Corporation | 117.67B | -0.16% | 5,417,226 | 24.78B |
| 17 | BMY | Bristol-Myers Squibb Company | 115.27B | 1.40% | 9,274,358 | 48.48B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 113.78B | 3.01% | 1,398,283 | 12.22B |
| 19 | SYK | Stryker Corporation | 112.88B | 4.20% | 3,371,248 | 25.27B |
| 20 | SNY | Sanofi | 103.23B | 0.85% | 4,205,565 | 54.60B |
| 21 | GSK | GSK plc | 101.98B | 2.19% | 4,848,758 | 43.29B |
| 22 | MDT | Medtronic plc | 98.63B | 3.06% | 10,254,956 | 35.48B |
| 23 | HCA | HCA Healthcare, Inc. | 95.32B | 0.78% | 1,283,512 | 76.39B |
| 24 | MCK | McKesson Corporation | 88.31B | 1.31% | 951,689 | 403.43B |
| 25 | ELV | Elevance Health, Inc. | 85.41B | 3.03% | 2,376,182 | 200.42B |
| 26 | BSX | Boston Scientific Corporation | 80.41B | 1.37% | 15,909,875 | 20.61B |
| 27 | CI | The Cigna Group | 78.96B | 3.26% | 2,291,518 | 277.89B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 73.60B | 1.49% | 824,536 | 14.92B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 51.76B | 0.37% | 4,639,246 | 28.48B |
| 30 | ARGX | argenx SE | 50.91B | -0.06% | 346,238 | 4.74B |
| 31 | COR | Cencora, Inc. | 50.77B | 0.47% | 1,795,376 | 328.68B |
| 32 | MDLN | Medline Inc. | 50.64B | -1.78% | 7,694,614 | 29.14B |
| 33 | EW | Edwards Lifesciences Corporation | 45.91B | 3.32% | 5,075,382 | 6.30B |
| 34 | CAH | Cardinal Health, Inc. | 42.76B | 0.03% | 2,321,937 | 250.74B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 42.12B | 0.36% | 674,101 | 4.45B |
| 36 | TEVA | Teva Pharmaceutical Industries Limited | 41.70B | -0.08% | 4,625,472 | 17.35B |
| 37 | BDX | Becton, Dickinson and Company | 40.64B | 3.05% | 3,465,309 | 22.23B |
| 38 | HLN | Haleon plc | 40.18B | 1.34% | 9,584,444 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.99B | 2.52% | 826,074 | 4.29B |
| 40 | HUM | Humana Inc. | 35.46B | 7.69% | 2,904,307 | 137.20B |
| 41 | ONC | BeOne Medicines AG | 35.03B | 1.39% | 268,357 | 5.70B |
| 42 | WAT | Waters Corporation | 34.57B | 1.19% | 1,263,983 | 3.77B |
| 43 | ZTS | Zoetis Inc. | 32.26B | 0.35% | 18,429,867 | 9.53B |
| 44 | A | Agilent Technologies, Inc. | 31.91B | 1.29% | 1,649,626 | 7.07B |
| 45 | ALC | Alcon Inc. | 31.27B | 2.84% | 2,842,177 | 10.63B |
| 46 | RVMD | Revolution Medicines, Inc. | 30.98B | 1.09% | 1,422,621 | - |
| 47 | RPRX | Royalty Pharma plc | 29.77B | 0.10% | 3,456,784 | 2.44B |
| 48 | RMD | ResMed Inc. | 29.56B | 2.53% | 1,368,941 | 5.54B |
| 49 | BIIB | Biogen Inc. | 29.43B | 0.71% | 1,145,409 | 9.94B |
| 50 | CNC | Centene Corporation | 29.29B | 5.23% | 9,427,268 | 178.33B |
| 51 | NTRA | Natera, Inc. | 29.25B | 2.55% | 1,566,907 | 2.50B |
| 52 | IQV | IQVIA Holdings Inc. | 29.22B | 0.87% | 1,212,986 | 16.63B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.34B | 0.96% | 4,299,775 | 20.98B |
| 54 | VEEV | Veeva Systems Inc. | 26.04B | 0.06% | 1,873,057 | 3.20B |
| 55 | INSM | Insmed Incorporated | 25.14B | 11.66% | 8,274,773 | 819.56M |
| 56 | PHG | Koninklijke Philips N.V. | 24.70B | 1.05% | 1,132,317 | 20.34B |
| 57 | UTHR | United Therapeutics Corporation | 24.69B | 2.08% | 397,478 | 3.17B |
| 58 | BNTX | BioNTech SE | 23.69B | 0.34% | 384,790 | 3.23B |
| 59 | DXCM | DexCom, Inc. | 23.59B | 3.05% | 6,099,249 | 4.82B |
| 60 | WST | West Pharmaceutical Services, Inc. | 22.05B | -3.17% | 1,124,716 | 3.22B |
| 61 | ILMN | Illumina, Inc. | 22.04B | 2.24% | 2,839,151 | 4.39B |
| 62 | MTD | Mettler-Toledo International Inc. | 21.67B | -0.56% | 197,637 | 4.09B |
| 63 | MRNA | Moderna, Inc. | 21.14B | 0.74% | 11,248,182 | 2.23B |
| 64 | LH | Labcorp Holdings Inc. | 21.10B | 0.89% | 730,037 | 14.14B |
| 65 | DGX | Quest Diagnostics Incorporated | 21.05B | 0.19% | 754,932 | 11.28B |
| 66 | ROIV | Roivant Sciences Ltd. | 21.03B | 1.48% | 8,436,991 | 13.31M |
| 67 | STE | STERIS plc | 20.68B | 4.46% | 1,822,788 | 5.94B |
| 68 | VTRS | Viatris Inc. | 20.00B | 1.48% | 12,267,772 | 14.56B |
| 69 | INCY | Incyte Corporation | 19.80B | -1.19% | 1,577,441 | 5.36B |
| 70 | THC | Tenet Healthcare Corporation | 16.87B | 2.19% | 1,290,231 | 21.46B |
| 71 | GMAB | Genmab A/S | 16.50B | 3.48% | 2,243,947 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 16.13B | 4.76% | 2,434,827 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 15.67B | 3.46% | 1,309,378 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 14.76B | -0.43% | 879,685 | 998.25M |
| 75 | SMMT | Summit Therapeutics Inc. | 14.71B | 1.55% | 2,238,440 | - |
| 76 | JAZZ | Jazz Pharmaceuticals plc | 14.30B | 1.89% | 807,774 | 4.44B |
| 77 | GH | Guardant Health, Inc. | 13.25B | 3.34% | 2,547,024 | 1.08B |
| 78 | RGC | Regencell Bioscience Holdings Limited | 13.03B | -3.59% | 165,865 | - |
| 79 | SOLV | Solventum Corporation | 13.01B | 1.32% | 2,319,247 | 8.26B |
| 80 | BBIO | BridgeBio Pharma, Inc. | 12.92B | 1.96% | 2,409,937 | 579.96M |
| 81 | DVA | DaVita Inc. | 12.87B | 0.81% | 1,374,497 | 13.84B |
| 82 | SNN | Smith & Nephew plc | 12.72B | 3.30% | 915,735 | 6.16B |
| 83 | PEN | Penumbra, Inc. | 12.70B | 0.34% | 258,783 | 1.45B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 12.53B | 0.60% | 1,408,863 | 1.06B |
| 85 | EXEL | Exelixis, Inc. | 12.43B | -0.50% | 2,766,761 | 2.38B |
| 86 | MEDP | Medpace Holdings, Inc. | 11.99B | 0.59% | 363,540 | 2.68B |
| 87 | ALGN | Align Technology, Inc. | 11.87B | 0.72% | 630,627 | 4.10B |
| 88 | FMS | Fresenius Medical Care AG | 11.86B | 2.21% | 829,022 | 22.32B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.76B | 2.66% | 235,015 | 1.13B |
| 90 | COO | The Cooper Companies, Inc. | 11.70B | 1.64% | 2,818,347 | 4.15B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 11.53B | 3.49% | 633,132 | 708.24M |
| 92 | BTSG | BrightSpring Health Services, Inc. | 11.41B | 0.78% | 2,717,017 | 13.65B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.13B | 1.67% | 1,544,470 | 622.01M |
| 94 | RVTY | Revvity, Inc. | 11.10B | 0.35% | 1,328,926 | 2.90B |
| 95 | RDY | Dr. Reddy's Laboratories Limited | 11.05B | -5.18% | 6,228,230 | 3.58B |
| 96 | PODD | Insulet Corporation | 10.97B | 2.71% | 1,341,124 | 2.90B |
| 97 | EHC | Encompass Health Corporation | 10.72B | 3.11% | 1,069,147 | 6.07B |
| 98 | ELAN | Elanco Animal Health Incorporated | 10.70B | -1.34% | 10,856,942 | 4.89B |
| 99 | GMED | Globus Medical, Inc. | 10.33B | -0.72% | 2,415,055 | 3.10B |
| 100 | UHS | Universal Health Services, Inc. | 10.27B | 0.83% | 880,969 | 17.76B |
| 101 | BMRN | BioMarin Pharmaceutical Inc. | 10.22B | 0.57% | 1,205,270 | 3.24B |
| 102 | ENSG | The Ensign Group, Inc. | 10.20B | 3.91% | 629,216 | 5.27B |
| 103 | MOH | Molina Healthcare, Inc. | 9.98B | 3.45% | 956,856 | 43.10B |
| 104 | ABVX | ABIVAX Société Anonyme | 9.63B | -0.61% | 734,477 | 5.37M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | 3.43% | 426,105 | 7.46M |
| 106 | MASI | Masimo Corporation | 9.35B | 0.03% | 823,708 | 1.56B |
| 107 | ICLR | ICON Public Limited Company | 9.31B | 2.51% | 803,699 | 8.10B |
| 108 | CYTK | Cytokinetics, Incorporated | 9.31B | 0.34% | 2,418,512 | 105.82M |
| 109 | BAX | Baxter International Inc. | 9.24B | 2.05% | 7,160,752 | 11.32B |
| 110 | KRYS | Krystal Biotech, Inc. | 9.15B | -0.82% | 316,250 | 417.30M |
| 111 | IBRX | ImmunityBio, Inc. | 8.50B | 0.12% | 9,900,490 | 140.98M |
| 112 | TEM | Tempus AI, Inc. | 8.43B | -3.12% | 6,441,719 | 1.36B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.41B | 6.81% | 4,874,519 | 1.51B |
| 114 | CRL | Charles River Laboratories International, Inc. | 8.13B | 0.14% | 724,908 | 4.03B |
| 115 | NUVL | Nuvalent, Inc. | 8.10B | -1.92% | 673,853 | - |
| 116 | GKOS | Glaukos Corporation | 8.01B | 0.73% | 667,105 | 551.35M |
| 117 | HSIC | Henry Schein, Inc. | 7.90B | 0.52% | 1,659,045 | 13.38B |
| 118 | PCVX | Vaxcyte, Inc. | 7.80B | 0.07% | 1,260,710 | - |
| 119 | ATR | AptarGroup, Inc. | 7.53B | -1.59% | 696,844 | 3.87B |
| 120 | TECH | Bio-Techne Corporation | 7.43B | 0.01% | 1,767,173 | 1.21B |
| 121 | OSCR | Oscar Health, Inc. | 7.15B | 7.86% | 13,223,600 | 13.30B |
| 122 | QGEN | Qiagen N.V. | 6.97B | 3.28% | 3,286,103 | 2.10B |
| 123 | KYMR | Kymera Therapeutics, Inc. | 6.87B | -0.65% | 385,165 | 51.48M |
| 124 | BRKR | Bruker Corporation | 6.81B | 3.37% | 1,917,247 | 3.46B |
| 125 | HQY | HealthEquity, Inc. | 6.80B | -1.46% | 1,281,689 | 1.31B |
| 126 | MIRM | Mirum Pharmaceuticals, Inc. | 6.52B | 0.67% | 662,806 | 569.61M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 6.52B | -1.82% | 1,760,535 | - |
| 128 | PACS | PACS Group, Inc. | 6.49B | 28.56% | 3,624,437 | 5.43B |
| 129 | BIO | Bio-Rad Laboratories, Inc. | 6.47B | -0.85% | 277,685 | 2.59B |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 6.43B | -3.43% | 645,705 | 74.06M |
| 131 | RGEN | Repligen Corporation | 6.41B | -1.99% | 1,465,079 | 763.34M |
| 132 | ALKS | Alkermes plc | 6.38B | 7.95% | 3,979,124 | 1.56B |
| 133 | CGON | CG Oncology, Inc. | 6.36B | 3.97% | 1,644,599 | 5.07M |
| 134 | GRFS | Grifols, S.A. | 6.29B | -3.21% | 757,677 | 8.58B |
| 135 | LNTH | Lantheus Holdings, Inc. | 6.27B | 2.30% | 1,230,207 | 1.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.26B | 4.49% | 655,396 | 217.17M |
| 137 | PTCT | PTC Therapeutics, Inc. | 6.22B | -2.38% | 2,212,245 | 827.11M |
| 138 | APGE | Apogee Therapeutics, Inc. | 6.22B | -1.97% | 497,173 | - |
| 139 | CNTA | Centessa Pharmaceuticals plc | 6.13B | 0.05% | 1,524,360 | 15.00M |
| 140 | BLTE | Belite Bio, Inc | 6.12B | 2.35% | 87,196 | - |
| 141 | TGTX | TG Therapeutics, Inc. | 6.03B | -1.39% | 2,382,780 | 700.35M |
| 142 | CELC | Celcuity Inc. | 6.03B | -0.76% | 1,175,505 | - |
| 143 | COGT | Cogent Biosciences, Inc. | 5.90B | 1.26% | 1,187,158 | - |
| 144 | SRRK | Scholar Rock Holding Corporation | 5.89B | 1.74% | 1,318,659 | - |
| 145 | IMVT | Immunovant, Inc. | 5.83B | -1.41% | 1,145,132 | - |
| 146 | HIMS | Hims & Hers Health, Inc. | 5.79B | -14.10% | 53,634,910 | 2.37B |
| 147 | BLCO | Bausch + Lomb Corporation | 5.72B | - | 582,456 | 5.10B |
| 148 | TFX | Teleflex Incorporated | 5.71B | -0.53% | 771,116 | 2.13B |
| 149 | AVTR | Avantor, Inc. | 5.58B | 2.51% | 9,756,056 | 6.55B |
| 150 | CHE | Chemed Corporation | 5.55B | -0.42% | 248,540 | 2.54B |
| 151 | CORT | Corcept Therapeutics Incorporated | 5.49B | -0.08% | 771,273 | 769.10M |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.32B | -1.40% | 789,661 | 7.50M |
| 153 | APLS | Apellis Pharmaceuticals, Inc. | 5.26B | 0.10% | 7,931,662 | 1.11B |
| 154 | LEGN | Legend Biotech Corporation | 5.23B | 10.48% | 5,050,401 | 1.03B |
| 155 | CRSP | CRISPR Therapeutics AG | 5.10B | -2.18% | 971,748 | 4.10M |
| 156 | LQDA | Liquidia Corporation | 5.03B | 6.53% | 3,928,519 | 288.07M |
| 157 | STVN | Stevanato Group S.p.A. | 4.98B | -0.22% | 565,267 | 1.39B |
| 158 | DOCS | Doximity, Inc. | 4.89B | 0.72% | 3,589,051 | 637.78M |
| 159 | CAI | Caris Life Sciences, Inc. | 4.74B | 5.14% | 3,278,572 | 907.29M |
| 160 | DNTH | Dianthus Therapeutics, Inc. | 4.71B | -1.11% | 347,128 | 1.34M |
| 161 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.58B | 1.90% | 511,021 | 754.05M |
| 162 | NAMS | NewAmsterdam Pharma Company N.V. | 4.47B | -1.77% | 2,146,823 | 22.57M |
| 163 | SHC | Sotera Health Company | 4.46B | 1.30% | 14,767,599 | 1.19B |
| 164 | LGND | Ligand Pharmaceuticals Incorporated | 4.45B | 0.69% | 164,216 | 274.48M |
| 165 | RDNT | RadNet, Inc. | 4.40B | 0.18% | 2,042,723 | 2.14B |
| 166 | BLLN | BillionToOne, Inc. | 4.33B | -11.05% | 1,306,362 | 354.54M |
| 167 | MANE | Veradermics, Incorporated | 4.28B | -3.91% | 560,485 | - |
| 168 | HNGE | Hinge Health, Inc. | 4.27B | 0.88% | 1,155,259 | 646.34M |
| 169 | AMRX | Amneal Pharmaceuticals, Inc. | 4.02B | -1.41% | 1,266,466 | 3.05B |
| 170 | TVTX | Travere Therapeutics, Inc. | 3.98B | -1.54% | 1,763,986 | 536.20M |
| 171 | NVST | Envista Holdings Corporation | 3.95B | 0.33% | 2,939,205 | 2.81B |
| 172 | LIVN | LivaNova PLC | 3.94B | 2.37% | 1,006,737 | 1.43B |
| 173 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.89B | 0.98% | 1,331,657 | 18.07M |
| 174 | IRTC | iRhythm Holdings, Inc. | 3.89B | 1.26% | 625,496 | 787.85M |
| 175 | ORKA | Oruka Therapeutics, Inc. | 3.87B | -1.57% | 1,088,250 | - |
| 176 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.81B | -0.03% | 3,354,099 | 596.96M |
| 177 | ALHC | Alignment Healthcare, Inc. | 3.80B | 7.11% | 10,810,484 | 4.26B |
| 178 | WAY | Waystar Holding Corp. | 3.72B | -2.56% | 1,951,811 | 1.16B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | -0.37% | 1,125,155 | 1.10B |
| 180 | EWTX | Edgewise Therapeutics, Inc. | 3.66B | -1.59% | 1,168,380 | - |
| 181 | MMSI | Merit Medical Systems, Inc. | 3.65B | 1.33% | 857,524 | 1.54B |
| 182 | VKTX | Viking Therapeutics, Inc. | 3.64B | -1.26% | 1,328,511 | - |
| 183 | TLX | Telix Pharmaceuticals Limited | 3.53B | -4.06% | 133,879 | 803.79M |
| 184 | OGN | Organon & Co. | 3.50B | -0.15% | 4,864,461 | 6.16B |
| 185 | TWST | Twist Bioscience Corporation | 3.48B | -0.46% | 1,143,391 | 409.48M |
| 186 | TNGX | Tango Therapeutics, Inc. | 3.39B | 0.09% | 1,387,823 | 62.38M |
| 187 | MMED | MiniMed Group, Inc. | 3.34B | 6.54% | 1,054,949 | 2.99B |
| 188 | WRBY | Warby Parker Inc. | 3.31B | -6.39% | 3,096,096 | 890.57M |
| 189 | CON | Concentra Group Holdings Parent, Inc. | 3.27B | 2.28% | 1,633,606 | 2.23B |
| 190 | ERAS | Erasca, Inc. | 3.23B | -0.57% | 3,763,972 | - |
| 191 | VCYT | Veracyte, Inc. | 3.16B | -0.35% | 742,322 | 541.74M |
| 192 | BEAM | Beam Therapeutics Inc. | 3.14B | -0.54% | 1,438,670 | 164.01M |
| 193 | RCUS | Arcus Biosciences, Inc. | 3.13B | 0.16% | 691,073 | 236.00M |
| 194 | BKD | Brookdale Senior Living Inc. | 3.10B | 1.33% | 2,685,635 | 3.00B |
| 195 | DNLI | Denali Therapeutics Inc. | 3.09B | -1.07% | 1,792,298 | - |
| 196 | ICUI | ICU Medical, Inc. | 3.08B | -1.16% | 301,864 | 2.16B |
| 197 | OPCH | Option Care Health, Inc. | 3.08B | -1.21% | 6,260,261 | 5.67B |
| 198 | LFST | LifeStance Health Group, Inc. | 3.08B | 3.39% | 8,688,080 | 1.49B |
| 199 | DYN | Dyne Therapeutics, Inc. | 3.04B | -0.49% | 846,681 | - |
| 200 | ALMS | Alumis Inc. | 2.99B | -0.63% | 602,344 | 24.05M |
| 201 | NHC | National HealthCare Corporation | 2.96B | -0.15% | 122,666 | 1.53B |
| 202 | SUPN | Supernus Pharmaceuticals, Inc. | 2.93B | 2.35% | 589,558 | 776.83M |
| 203 | PRVA | Privia Health Group, Inc. | 2.90B | 1.10% | 969,944 | 2.25B |
| 204 | KLRA | Kailera Therapeutics, Inc. | 2.89B | -2.75% | 359,206 | - |
| 205 | ITGR | Integer Holdings Corporation | 2.89B | 0.15% | 611,232 | 1.86B |
| 206 | SLNO | Soleno Therapeutics, Inc. | 2.76B | -0.02% | 1,775,897 | 285.01M |
| 207 | GPCR | Structure Therapeutics Inc. | 2.69B | -1.25% | 556,769 | - |
| 208 | GRAL | GRAIL, Inc. | 2.66B | 1.18% | 416,132 | 156.12M |
| 209 | TXG | 10x Genomics, Inc. | 2.66B | 2.05% | 2,744,996 | 638.78M |
| 210 | NKTR | Nektar Therapeutics | 2.65B | -0.37% | 774,310 | 55.63M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 2.64B | 2.05% | 1,265,740 | 670.00M |
| 212 | VERA | Vera Therapeutics, Inc. | 2.63B | 0.25% | 663,601 | - |
| 213 | IRON | Disc Medicine, Inc. | 2.62B | -1.17% | 691,811 | - |
| 214 | ARQT | Arcutis Biotherapeutics, Inc. | 2.59B | -2.59% | 2,313,851 | 415.62M |
| 215 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 6.85% | 1,136,858 | - |
| 216 | TARS | Tarsus Pharmaceuticals, Inc. | 2.57B | 0.30% | 682,779 | 535.08M |
| 217 | IMNM | Immunome, Inc. | 2.57B | -1.35% | 1,236,295 | 4.02M |
| 218 | HTFL | HeartFlow, Inc. | 2.54B | 0.10% | 1,211,682 | 176.03M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.51B | -0.87% | 773,792 | 865.00K |
| 220 | HAE | Haemonetics Corporation | 2.51B | 3.39% | 971,218 | 1.33B |
| 221 | RLAY | Relay Therapeutics, Inc. | 2.48B | 0.62% | 2,017,512 | 10.68M |
| 222 | IDYA | IDEAYA Biosciences, Inc. | 2.47B | -0.04% | 726,865 | 225.27M |
| 223 | KOD | Kodiak Sciences Inc. | 2.47B | -0.90% | 407,133 | - |
| 224 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | -1.58% | 426,631 | - |
| 225 | ACHC | Acadia Healthcare Company, Inc. | 2.39B | 4.04% | 2,976,031 | 3.37B |
| 226 | PBH | Prestige Consumer Healthcare Inc. | 2.39B | -0.47% | 732,998 | 1.10B |
| 227 | DFTX | Definium Therapeutics, Inc. | 2.31B | -1.12% | 1,013,884 | - |
| 228 | NBTX | Nanobiotix S.A. | 2.29B | -9.92% | 128,405 | 38.27M |
| 229 | HCM | HUTCHMED (China) Limited | 2.24B | -1.55% | 28,148 | 548.51M |
| 230 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.24B | 2.56% | 3,319,992 | 885.72M |
| 231 | LMAT | LeMaitre Vascular, Inc. | 2.22B | -4.35% | 626,486 | 256.28M |
| 232 | GRDN | Guardian Pharmacy Services, Inc. | 2.21B | -2.08% | 296,483 | 1.46B |
| 233 | TMDX | TransMedics Group, Inc. | 2.21B | -0.58% | 1,535,619 | 635.89M |
| 234 | XRAY | DENTSPLY SIRONA Inc. | 2.20B | 0.82% | 4,794,451 | 3.68B |
| 235 | ZLAB | Zai Lab Limited | 2.19B | -0.31% | 464,965 | 453.28M |
| 236 | ADPT | Adaptive Biotechnologies Corporation | 2.18B | 0.66% | 1,233,352 | 295.41M |
| 237 | AXGN | Axogen, Inc. | 2.18B | 0.34% | 651,481 | 238.11M |
| 238 | ASTH | Astrana Health, Inc. | 2.17B | 2.74% | 601,422 | 3.53B |
| 239 | NVCR | NovoCure Limited | 2.12B | 1.16% | 1,488,286 | 674.41M |
| 240 | TRVI | Trevi Therapeutics, Inc. | 2.10B | -0.81% | 1,128,152 | - |
| 241 | TYRA | Tyra Biosciences, Inc. | 2.07B | 2.53% | 471,279 | - |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.06B | 1.72% | 1,335,101 | 298.30M |
| 243 | PHVS | Pharvaris N.V. | 2.04B | 4.34% | 321,671 | - |
| 244 | SEM | Select Medical Holdings Corporation | 2.04B | 0.06% | 1,237,041 | 5.52B |
| 245 | ESTA | Establishment Labs Holdings Inc. | 2.03B | -3.24% | 578,429 | 229.58M |
| 246 | STOK | Stoke Therapeutics, Inc. | 2.02B | -0.46% | 297,929 | 32.08M |
| 247 | BHC | Bausch Health Companies Inc. | 2.02B | 0.74% | 982,095 | 10.53B |
| 248 | SRPT | Sarepta Therapeutics, Inc. | 2.02B | -1.39% | 2,830,399 | 2.18B |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.01B | -1.29% | 3,703,193 | 52.04M |
| 250 | OMCL | Omnicell, Inc. | 1.99B | 0.92% | 701,014 | 1.23B |
| 251 | AAPG | Ascentage Pharma Group International | 1.98B | -2.31% | 12,063 | 82.08M |
| 252 | GENB | Generate Biomedicines, Inc. | 1.97B | 7.79% | 292,864 | 30.30M |
| 253 | TSHA | Taysha Gene Therapies, Inc. | 1.97B | 0.44% | 1,636,803 | 7.47M |
| 254 | NTLA | Intellia Therapeutics, Inc. | 1.95B | -2.98% | 4,657,997 | 66.09M |
| 255 | ADMA | ADMA Biologics, Inc. | 1.95B | 6.73% | 8,319,395 | 509.86M |
| 256 | MD | Pediatrix Medical Group, Inc. | 1.90B | 1.33% | 793,409 | 1.93B |
| 257 | ANAB | AnaptysBio, Inc. | 1.89B | -3.45% | 853,939 | 232.39M |
| 258 | NEOG | Neogen Corporation | 1.87B | -0.46% | 1,728,178 | 870.56M |
| 259 | MESO | Mesoblast Limited | 1.86B | -0.48% | 144,622 | 65.38M |
| 260 | SION | Sionna Therapeutics, Inc. | 1.85B | -10.90% | 525,215 | - |
| 261 | PGNY | Progyny, Inc. | 1.84B | 3.99% | 2,373,183 | 1.29B |
| 262 | QURE | uniQure N.V. | 1.84B | 5.28% | 4,094,545 | 18.09M |
| 263 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.19% | 1,057,078 | 11.13M |
| 264 | AHG | Akso Health Group | 1.81B | -1.42% | 185,601 | 14.84M |
| 265 | SGRY | Surgery Partners, Inc. | 1.81B | 1.38% | 1,825,809 | 3.34B |
| 266 | ANIP | ANI Pharmaceuticals, Inc. | 1.81B | 1.00% | 561,891 | 923.71M |
| 267 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -4.54% | 1,203,736 | 217.17M |
| 268 | LKFT | Lakefront Biotherapeutics NV | 1.80B | -0.44% | 106,961 | 1.20B |
| 269 | PVLA | Palvella Therapeutics, Inc. | 1.80B | 3.03% | 155,329 | - |
| 270 | ADUS | Addus HomeCare Corporation | 1.80B | 0.72% | 189,733 | 1.45B |
| 271 | OCS | Oculis Holding AG | 1.80B | -6.86% | 532,512 | 1.40M |
| 272 | RAPP | Rapport Therapeutics, Inc. | 1.78B | -3.15% | 300,981 | 20.00M |
| 273 | MBX | MBX Biosciences, Inc. | 1.76B | -7.73% | 1,052,653 | - |
| 274 | HRMY | Harmony Biosciences Holdings, Inc. | 1.75B | -0.10% | 1,043,979 | 899.11M |
| 275 | ZYME | Zymeworks Inc. | 1.75B | -0.54% | 723,952 | 81.26M |
| 276 | VRDN | Viridian Therapeutics, Inc. | 1.74B | -1.98% | 2,450,886 | 70.92M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.73B | 0.43% | 667,690 | 367.34M |
| 278 | CLOV | Clover Health Investments, Corp. | 1.73B | 2.50% | 7,567,865 | 2.21B |
| 279 | UFPT | UFP Technologies, Inc. | 1.71B | -0.62% | 258,398 | 608.85M |
| 280 | AGIO | Agios Pharmaceuticals, Inc. | 1.69B | 1.54% | 766,918 | 66.05M |
| 281 | NUVB | Nuvation Bio Inc. | 1.69B | 1.68% | 2,540,745 | 143.05M |
| 282 | VCEL | Vericel Corporation | 1.68B | 0.06% | 486,683 | 292.09M |
| 283 | INVA | Innoviva, Inc. | 1.68B | 0.98% | 582,016 | 420.69M |
| 284 | RXRX | Recursion Pharmaceuticals, Inc. | 1.67B | -3.37% | 14,572,495 | 66.41M |
| 285 | NRIX | Nurix Therapeutics, Inc. | 1.65B | -1.97% | 658,728 | 71.78M |
| 286 | PRCT | PROCEPT BioRobotics Corporation | 1.63B | 8.47% | 2,978,829 | 322.02M |
| 287 | ARDX | Ardelyx, Inc. | 1.63B | - | 1,823,000 | 427.68M |
| 288 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -5.68% | 523,146 | 42.95M |
| 289 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.61B | -2.96% | 1,084,679 | -665.00K |
| 290 | PLSE | Pulse Biosciences, Inc. | 1.59B | 22.12% | 517,218 | 751.00K |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | -3.78% | 29,883,263 | 285.61M |
| 292 | INBX | Inhibrx Biosciences, Inc. | 1.59B | -14.84% | 1,273,355 | 1.30M |
| 293 | VIR | Vir Biotechnology, Inc. | 1.59B | 1.18% | 1,235,986 | 65.50M |
| 294 | NVAX | Novavax, Inc. | 1.58B | 1.26% | 6,135,897 | 596.34M |
| 295 | ALMR | Alamar Biosciences, Inc. | 1.57B | -3.81% | 158,675 | 74.21M |
| 296 | PRGO | Perrigo Company plc | 1.54B | 0.45% | 2,947,298 | 4.18B |
| 297 | IMTX | Immatics N.V. | 1.53B | -1.30% | 483,102 | 56.67M |
| 298 | ATAI | AtaiBeckley Inc. | 1.52B | 2.72% | 5,166,069 | 4.09M |
| 299 | HCSG | Healthcare Services Group, Inc. | 1.52B | -0.92% | 412,965 | 1.85B |
| 300 | ABCL | AbCellera Biologics Inc. | 1.51B | -5.71% | 16,942,420 | 79.21M |
| 301 | AHCO | AdaptHealth Corp. | 1.50B | 0.09% | 1,869,426 | 3.29B |
| 302 | ENOV | Enovis Corporation | 1.50B | 4.88% | 2,441,062 | 2.28B |
| 303 | IMCR | Immunocore Holdings plc | 1.49B | 1.56% | 135,686 | 412.81M |
| 304 | PAHC | Phibro Animal Health Corporation | 1.48B | 0.72% | 471,019 | 1.50B |
| 305 | AVAH | Aveanna Healthcare Holdings Inc. | 1.48B | 3.49% | 1,240,254 | 2.43B |
| 306 | BCAX | Bicara Therapeutics Inc. | 1.47B | -2.36% | 352,854 | - |
| 307 | URGN | UroGen Pharma Ltd. | 1.45B | -4.88% | 927,547 | 140.49M |
| 308 | PGEN | Precigen, Inc. | 1.44B | -2.86% | 2,322,181 | 9.68M |
| 309 | ARDT | Ardent Health, Inc. | 1.44B | 1.21% | 267,094 | 6.43B |
| 310 | MAZE | Maze Therapeutics, Inc. | 1.43B | 1.02% | 350,464 | 20.00M |
| 311 | KALV | KalVista Pharmaceuticals, Inc. | 1.42B | 0.07% | 2,247,528 | 73.62M |
| 312 | STAA | STAAR Surgical Company | 1.40B | 1.26% | 902,029 | 239.44M |
| 313 | DMRA | Damora Therapeutics, Inc. | 1.39B | -5.21% | 528,493 | - |
| 314 | BHVN | Biohaven Ltd. | 1.39B | 1.32% | 1,818,594 | - |
| 315 | FTRE | Fortrea Holdings Inc. | 1.38B | -2.54% | 1,339,318 | 2.71B |
| 316 | MPLT | MapLight Therapeutics, Inc. | 1.37B | 0.65% | 179,171 | - |
| 317 | ATRC | AtriCure, Inc. | 1.35B | 1.48% | 851,478 | 552.16M |
| 318 | AVBP | ArriVent BioPharma, Inc. | 1.35B | -0.17% | 412,581 | - |
| 319 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | 1.01% | 904,284 | - |
| 320 | GHRS | GH Research PLC | 1.34B | 1.32% | 94,963 | - |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.33B | -3.45% | 1,577,479 | - |
| 322 | WVE | Wave Life Sciences Ltd. | 1.31B | -3.96% | 4,998,664 | 71.80M |
| 323 | SVRA | Savara Inc. | 1.29B | -0.78% | 725,962 | - |
| 324 | INSP | Inspire Medical Systems, Inc. | 1.27B | 1.64% | 969,872 | 915.25M |
| 325 | CMPS | COMPASS Pathways plc | 1.26B | -2.90% | 1,816,151 | - |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.26B | -1.19% | 244,863 | 83.72M |
| 327 | AVLN | Avalyn Pharma Inc. | 1.25B | 1.12% | 308,642 | - |
| 328 | JBIO | Jade Biosciences, Inc. | 1.25B | 1.49% | 366,720 | - |
| 329 | PNTG | The Pennant Group, Inc. | 1.23B | 3.78% | 247,742 | 1.02B |
| 330 | TDOC | Teladoc Health, Inc. | 1.22B | -2.17% | 6,862,292 | 2.51B |
| 331 | OLMA | Olema Pharmaceuticals, Inc. | 1.22B | -5.99% | 2,603,284 | - |
| 332 | DBVT | DBV Technologies S.A. | 1.21B | -2.06% | 174,566 | 5.74M |
| 333 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.20B | -1.69% | 2,040,841 | 204.73M |
| 334 | IVA | Inventiva S.A. | 1.20B | -0.86% | 89,174 | 7.94M |
| 335 | ATEC | Alphatec Holdings, Inc. | 1.19B | 10.73% | 5,348,877 | 787.08M |
| 336 | WGS | GeneDx Holdings Corp. | 1.17B | -0.30% | 1,386,662 | 442.68M |
| 337 | AGL | agilon health, inc. | 1.16B | 16.66% | 670,963 | 5.82B |
| 338 | AVNS | Avanos Medical, Inc. | 1.16B | -0.32% | 1,575,372 | 715.90M |
| 339 | COLL | Collegium Pharmaceutical, Inc. | 1.16B | -0.34% | 492,597 | 796.33M |
| 340 | COAG | Hemab Therapeutics Holdings, Inc. | 1.14B | 3.60% | 142,739 | - |
| 341 | AMN | AMN Healthcare Services, Inc. | 1.14B | -2.64% | 1,604,482 | 3.42B |
| 342 | EYPT | EyePoint, Inc. | 1.14B | -2.58% | 764,199 | 7.61M |
| 343 | ZBIO | Zenas BioPharma, Inc. | 1.14B | -6.08% | 296,918 | 10.00M |
| 344 | NEO | NeoGenomics, Inc. | 1.14B | 1.04% | 1,721,094 | 745.97M |
| 345 | NNNN | Anbio Biotechnology | 1.13B | 1.78% | 24,472 | 8.65M |
| 346 | AORT | Artivion, Inc. | 1.12B | -2.98% | 953,779 | 458.69M |
| 347 | SEPN | Septerna, Inc. | 1.12B | 5.39% | 408,166 | 72.26M |
| 348 | ALVO | Alvotech | 1.11B | -1.11% | 377,366 | 562.04M |
| 349 | CDNA | CareDx, Inc. | 1.11B | -0.70% | 437,814 | 412.82M |
| 350 | AKTS | Aktis Oncology, Inc. | 1.09B | 7.99% | 149,696 | 8.28M |
| 351 | BFLY | Butterfly Network, Inc. | 1.09B | -0.95% | 3,366,507 | 102.92M |
| 352 | IRMD | IRADIMED CORPORATION | 1.08B | 0.51% | 109,683 | 86.28M |
| 353 | CNMD | CONMED Corporation | 1.08B | 2.10% | 324,796 | 1.37B |
| 354 | HROW | Harrow, Inc. | 1.08B | -23.69% | 5,407,585 | 268.68M |
| 355 | XERS | Xeris Biopharma Holdings, Inc. | 1.08B | 1.95% | 1,749,577 | 314.85M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.07B | -1.43% | 1,126,780 | 1.64B |
| 357 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.07B | 4.33% | 6,253,566 | 69.64M |
| 358 | OMER | Omeros Corporation | 1.07B | 2.79% | 1,099,879 | - |
| 359 | EVO | Evotec SE | 1.06B | -1.96% | 115,838 | 859.03M |
| 360 | CRON | Cronos Group Inc. | 1.04B | 0.73% | 1,769,037 | 159.54M |
| 361 | BLFS | BioLife Solutions, Inc. | 1.04B | -2.30% | 298,122 | 101.66M |
| 362 | INNV | InnovAge Holding Corp. | 1.02B | 2.58% | 325,325 | 949.17M |
| 363 | MNKD | MannKind Corporation | 1.01B | -2.38% | 5,514,041 | 360.78M |
| 364 | LMRI | Lumexa Imaging Holdings, Inc. | 1.01B | 3.35% | 479,343 | 1.03B |
| 365 | TNDM | Tandem Diabetes Care, Inc. | 1.01B | -0.54% | 2,367,731 | 1.03B |
| 366 | PHAT | Phathom Pharmaceuticals, Inc. | 995.26M | 2.54% | 1,024,791 | 204.89M |
| 367 | CGEM | Cullinan Therapeutics, Inc. | 992.55M | 9.64% | 1,929,514 | - |
| 368 | DSGN | Design Therapeutics, Inc. | 986.20M | 1.15% | 496,920 | - |
| 369 | SLS | SELLAS Life Sciences Group, Inc. | 963.26M | -0.57% | 5,902,700 | - |
| 370 | SDGR | Schrödinger, Inc. | 948.21M | -0.24% | 1,020,379 | 254.91M |
| 371 | NUTX | Nutex Health Inc. | 932.28M | 1.96% | 94,490 | 879.95M |
| 372 | USPH | U.S. Physical Therapy, Inc. | 926.06M | 2.41% | 376,176 | 787.69M |
| 373 | XNCR | Xencor, Inc. | 922.32M | -2.74% | 664,325 | 97.36M |
| 374 | PHAR | Pharming Group N.V. | 919.15M | 3.72% | 8,201 | 369.49M |
| 375 | ORIC | ORIC Pharmaceuticals, Inc. | 914.06M | -1.78% | 908,082 | - |
| 376 | GDRX | GoodRx Holdings, Inc. | 911.04M | -5.28% | 1,374,548 | 787.89M |
| 377 | SANA | Sana Biotechnology, Inc. | 907.23M | -8.43% | 4,527,094 | - |
| 378 | MGTX | MeiraGTx Holdings plc | 906.29M | -1.11% | 359,413 | 81.39M |
| 379 | PCRX | Pacira BioSciences, Inc. | 898.71M | 0.44% | 608,791 | 734.86M |
| 380 | GERN | Geron Corporation | 898.13M | 0.72% | 26,741,812 | 196.12M |
| 381 | LBRX | LB Pharmaceuticals Inc | 892.67M | -4.80% | 88,980 | - |
| 382 | VOR | Vor Biopharma Inc. | 892.44M | -4.52% | 1,225,089 | - |
| 383 | ANNX | Annexon, Inc. | 891.30M | -4.23% | 1,189,659 | - |
| 384 | OMDA | Omada Health, Inc. | 886.38M | 1.50% | 1,354,854 | 283.30M |
| 385 | JANX | Janux Therapeutics, Inc. | 878.78M | 1.26% | 665,927 | 13.73M |
| 386 | INMD | InMode Ltd. | 876.25M | 0.44% | 1,101,898 | 374.64M |
| 387 | DRTS | Alpha Tau Medical Ltd. | 869.54M | -4.45% | 875,853 | - |
| 388 | TALK | Talkspace, Inc. | 867.72M | -0.19% | 1,463,037 | 238.37M |
| 389 | ANRO | Alto Neuroscience, Inc. | 863.35M | 0.41% | 206,921 | - |
| 390 | KURA | Kura Oncology, Inc. | 859.22M | 1.79% | 1,840,027 | 71.64M |
| 391 | SPRY | ARS Pharmaceuticals, Inc. | 856.96M | 0.35% | 1,128,632 | 84.28M |
| 392 | TBPH | Theravance Biopharma, Inc. | 849.59M | -0.24% | 272,333 | 109.78M |
| 393 | ABUS | Arbutus Biopharma Corporation | 848.81M | -1.82% | 1,025,849 | 14.08M |
| 394 | BVS | Bioventus Inc. | 847.04M | -0.49% | 425,668 | 576.30M |
| 395 | SPTX | Seaport Therapeutics, Inc. | 845.79M | 4.89% | 155,042 | - |
| 396 | CTMX | CytomX Therapeutics, Inc. | 844.69M | 0.52% | 1,744,721 | 35.54M |
| 397 | ODTX | Odyssey Therapeutics, Inc. | 844.42M | 2.58% | 171,159 | 2.98M |
| 398 | DRUG | Bright Minds Biosciences Inc. | 836.91M | -2.20% | 126,789 | - |
| 399 | ABSI | Absci Corporation | 834.87M | -7.35% | 4,078,701 | 1.84M |
| 400 | OPK | OPKO Health, Inc. | 830.60M | -1.79% | 1,922,292 | 581.12M |
| 401 | SSII | SS Innovations International, Inc. | 821.75M | 0.74% | 54,237 | 42.48M |
| 402 | AURA | Aura Biosciences, Inc. | 819.86M | -3.17% | 478,460 | - |
| 403 | EVMN | Evommune, Inc. | 817.26M | -2.24% | 279,213 | 10.00M |
| 404 | ETON | Eton Pharmaceuticals, Inc. | 812.86M | -0.44% | 247,031 | 79.95M |
| 405 | BIOA | BioAge Labs, Inc. | 808.60M | 0.17% | 309,590 | 10.32M |
| 406 | AZTA | Azenta, Inc. | 808.01M | -2.34% | 1,482,666 | 596.48M |
| 407 | SGP | SpyGlass Pharma, Inc. | 806.92M | 1.60% | 42,718 | - |
| 408 | ESPR | Esperion Therapeutics, Inc. | 805.76M | - | 9,087,954 | 418.24M |
| 409 | ALLO | Allogene Therapeutics, Inc. | 793.56M | 0.88% | 10,034,074 | 22.00K |
| 410 | CERT | Certara, Inc. | 791.82M | -0.78% | 5,378,540 | 419.75M |
| 411 | RLMD | Relmada Therapeutics, Inc. | 781.42M | 1.22% | 1,441,978 | - |
| 412 | AMPH | Amphastar Pharmaceuticals, Inc. | 771.63M | -5.15% | 1,219,583 | 720.53M |
| 413 | SLDB | Solid Biosciences Inc. | 759.75M | 0.52% | 1,010,690 | - |
| 414 | QDEL | QuidelOrtho Corporation | 758.28M | 11.65% | 3,052,484 | 2.66B |
| 415 | TENX | Tenax Therapeutics, Inc. | 716.55M | 1.84% | 511,818 | - |
| 416 | EHAB | Enhabit, Inc. | 706.40M | 0.07% | 3,401,711 | 1.06B |
| 417 | HSTM | HealthStream, Inc. | 682.47M | 1.04% | 300,935 | 311.78M |
| 418 | ACRS | Aclaris Therapeutics, Inc. | 681.56M | -1.41% | 949,247 | 8.37M |
| 419 | STRO | Sutro Biopharma, Inc. | 677.79M | 4.07% | 224,683 | 102.48M |
| 420 | BWAY | BrainsWay Ltd. | 673.90M | 0.06% | 260,713 | 52.23M |
| 421 | IRWD | Ironwood Pharmaceuticals, Inc. | 673.27M | -1.92% | 1,863,760 | 361.51M |
| 422 | GYRE | Gyre Therapeutics, Inc. | 667.02M | 2.96% | 50,285 | 117.05M |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 653.22M | 2.31% | 1,122,236 | 122.29M |
| 424 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 650.67M | 3.04% | 224,457 | - |
| 425 | TLRY | Tilray Brands, Inc. | 645.32M | -1.81% | 2,802,360 | 858.28M |
| 426 | CADL | Candel Therapeutics, Inc. | 638.92M | -1.47% | 2,830,427 | - |
| 427 | CBLL | CeriBell, Inc. | 634.36M | -16.50% | 1,167,437 | 95.07M |
| 428 | PSNL | Personalis, Inc. | 632.52M | 4.50% | 1,482,577 | 64.52M |
| 429 | EIKN | Eikon Therapeutics, Inc. | 624.22M | 15.88% | 407,681 | - |
| 430 | KYTX | Kyverna Therapeutics, Inc. | 619.22M | -1.06% | 616,824 | - |
| 431 | TRAX | First Tracks Biotherapeutics, Inc. | 618.88M | -5.06% | 1,004,560 | - |
| 432 | ARVN | Arvinas, Inc. | 617.47M | -0.93% | 1,695,894 | 89.40M |
| 433 | SIBN | SI-BONE, Inc. | 616.46M | 19.72% | 3,354,656 | 206.22M |
| 434 | FBRX | Forte Biosciences, Inc. | 616.03M | -6.58% | 262,225 | - |
| 435 | CBIO | Crescent Biopharma, Inc. | 613.41M | -0.32% | 297,043 | 11.88M |
| 436 | AVR | Anteris Technologies Global Corp. | 603.60M | 2.92% | 565,983 | 1.85M |
| 437 | ALT | Altimmune, Inc. | 598.13M | -0.32% | 2,436,619 | 41.00K |
| 438 | PRME | Prime Medicine, Inc. | 596.04M | 1.85% | 3,057,111 | 4.03M |
| 439 | AGMB | AgomAb Therapeutics NV | 594.92M | -0.82% | 90,390 | - |
| 440 | CABA | Cabaletta Bio, Inc. | 591.87M | -4.97% | 4,022,451 | - |
| 441 | CRMD | CorMedix Inc. | 589.10M | -1.96% | 1,190,624 | 311.71M |
| 442 | PHR | Phreesia, Inc. | 583.93M | 0.42% | 1,051,429 | 480.59M |
| 443 | IMMX | Immix Biopharma, Inc. | 565.11M | 7.46% | 921,341 | - |
| 444 | CSTL | Castle Biosciences, Inc. | 565.05M | -2.15% | 571,225 | 339.92M |
| 445 | VALN | Valneva SE | 562.56M | -4.76% | 74,383 | 205.07M |
| 446 | DNA | Ginkgo Bioworks Holdings, Inc. | 544.81M | -3.81% | 1,320,870 | 151.40M |
| 447 | RIGL | Rigel Pharmaceuticals, Inc. | 543.41M | 12.10% | 1,230,485 | 299.77M |
| 448 | FDMT | 4D Molecular Therapeutics, Inc. | 540.54M | -4.17% | 459,002 | 88.24M |
| 449 | PROK | ProKidney Corp. | 537.49M | 0.56% | 976,806 | 893.00K |
| 450 | NPCE | NeuroPace, Inc. | 536.42M | 0.83% | 259,918 | 99.53M |
| 451 | CLYM | Climb Bio, Inc. | 533.57M | 0.45% | 310,815 | - |
| 452 | AVTX | Avalo Therapeutics, Inc. | 532.68M | -1.53% | 1,708,740 | 59.00K |
| 453 | TCMD | Tactile Systems Technology, Inc. | 530.75M | -1.55% | 362,613 | 343.52M |
| 454 | RGNX | REGENXBIO Inc. | 528.56M | 1.59% | 1,024,356 | 170.44M |
| 455 | TECX | Tectonic Therapeutic, Inc. | 527.58M | 1.60% | 237,572 | - |
| 456 | MDXG | MiMedx Group, Inc. | 527.27M | -0.56% | 1,422,376 | 389.42M |
| 457 | ANL | Adlai Nortye Ltd. | 526.00M | 1.47% | 133,908 | 5.00M |
| 458 | CTKB | Cytek Biosciences, Inc. | 521.74M | -1.94% | 966,101 | 204.17M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 517.02M | -4.15% | 1,401,880 | 44.55M |
| 460 | CERS | Cerus Corporation | 510.94M | 1.19% | 2,096,213 | 216.56M |
| 461 | CTNM | Contineum Therapeutics, Inc. | 510.70M | 0.07% | 126,426 | - |
| 462 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 463 | STTK | Shattuck Labs, Inc. | 500.35M | -5.70% | 1,085,574 | 1.00M |
| 464 | OCGN | Ocugen, Inc. | 497.62M | -0.68% | 6,725,167 | 4.47M |
| 465 | XOMA | XOMA Royalty Corporation | 497.48M | 0.70% | 83,679 | 48.56M |
| 466 | OVID | Ovid Therapeutics Inc. | 496.62M | 2.87% | 4,826,566 | 7.25M |
| 467 | PRTA | Prothena Corporation plc | 493.69M | -2.48% | 495,044 | 57.94M |
| 468 | NGNE | Neurogene Inc. | 492.52M | 2.10% | 103,482 | 925.00K |
| 469 | OFIX | Orthofix Medical Inc. | 492.34M | 4.37% | 354,724 | 825.37M |
| 470 | ASMB | Assembly Biosciences, Inc. | 489.81M | 1.35% | 60,753 | 71.10M |
| 471 | UPB | Upstream Bio, Inc. | 487.06M | -1.87% | 467,445 | 2.85M |
| 472 | CTEV | Claritev Corporation | 486.37M | -3.78% | 140,587 | 978.76M |
| 473 | KMDA | Kamada Ltd. | 484.49M | -0.24% | 19,633 | 180.46M |
| 474 | SRTA | Strata Critical Medical, Inc. | 473.30M | -3.36% | 1,376,379 | 228.58M |
| 475 | SGMT | Sagimet Biosciences Inc. | 472.40M | -0.52% | 793,385 | - |
| 476 | EPRX | Eupraxia Pharmaceuticals Inc. | 471.07M | 2.56% | 114,678 | - |
| 477 | EVH | Evolent Health, Inc. | 467.92M | 5.05% | 3,433,303 | 1.89B |
| 478 | PRLD | Prelude Therapeutics Incorporated | 466.68M | -3.33% | 309,912 | 12.14M |
| 479 | FULC | Fulcrum Therapeutics, Inc. | 463.77M | -0.57% | 598,664 | 80.00M |
| 480 | KIDS | OrthoPediatrics Corp. | 455.14M | 3.14% | 172,390 | 243.30M |
| 481 | ANGO | AngioDynamics, Inc. | 454.33M | 0.55% | 304,819 | 313.73M |
| 482 | ZURA | Zura Bio Limited | 450.68M | - | 509,404 | - |
| 483 | LYEL | Lyell Immunopharma, Inc. | 449.15M | 0.26% | 52,797 | 31.00K |
| 484 | FLGT | Fulgent Genetics, Inc. | 448.73M | -0.13% | 505,290 | 320.35M |
| 485 | LXEO | Lexeo Therapeutics, Inc. | 447.57M | -6.86% | 1,022,844 | - |
| 486 | AVIR | Atea Pharmaceuticals, Inc. | 440.15M | 1.66% | 310,187 | - |
| 487 | EBS | Emergent BioSolutions Inc. | 438.57M | -5.03% | 606,447 | 676.80M |
| 488 | BBNX | Beta Bionics, Inc. | 437.60M | -0.30% | 496,490 | 110.24M |
| 489 | ADCT | ADC Therapeutics SA | 436.27M | -1.44% | 1,201,430 | 79.18M |
| 490 | WEAV | Weave Communications, Inc. | 433.63M | -0.73% | 972,718 | 248.72M |
| 491 | NRC | NRC Health | 432.48M | 2.57% | 102,437 | 138.64M |
| 492 | CATX | Perspective Therapeutics, Inc. | 429.95M | -2.84% | 1,329,589 | 618.00K |
| 493 | LRMR | Larimar Therapeutics, Inc. | 429.04M | 0.98% | 912,326 | - |
| 494 | EOLS | Evolus, Inc. | 428.06M | 2.85% | 769,084 | 301.79M |
| 495 | AUTL | Autolus Therapeutics plc | 425.83M | 1.27% | 1,094,762 | 75.39M |
| 496 | PRTC | PureTech Health plc | 424.75M | -1.09% | 18,264 | 4.66M |
| 497 | CCRN | Cross Country Healthcare, Inc. | 424.20M | - | 1,424,369 | 1.00B |
| 498 | ENTA | Enanta Pharmaceuticals, Inc. | 421.65M | -6.02% | 367,018 | 69.21M |
| 499 | IVVD | Invivyd, Inc. | 421.38M | -1.32% | 1,028,848 | 53.43M |
| 500 | CGC | Canopy Growth Corporation | 419.06M | -2.68% | 6,838,909 | 203.04M |